Literature DB >> 18545237

Reduced-intensity conditioning in children: a reappraisal in 2008.

I Yaniv1, J Stein.   

Abstract

Transplant-related mortality and morbidity (both short and long term) have limited the effectiveness of SCT in children with both malignant and nonmalignant diseases. Reduced-intensity preparative regimens permit engraftment of allogeneic cells without many of the toxicities associated with standard TBI- and non-TBI-based conditioning. We review the concepts that underlie reduced-intensity transplantation (RIT) and highlight the experience of the technique in children. Although acute organ damage may be reduced after these transplants, the overall incidence of severe infections and of GvHD may be similar to that seen after standard-intensity transplantation. The relatively small numbers of children who have received RIT and the newness of the technique preclude long-term follow-up with which to monitor the incidence of associated long-term side effects and disease-free survival. Future refinements in RIT and appropriate patient selection for these procedures will hopefully extend its utility in the future.

Entities:  

Mesh:

Year:  2008        PMID: 18545237     DOI: 10.1038/bmt.2008.48

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP.

Authors:  A Lawitschka; M Faraci; I Yaniv; P Veys; P Bader; J Wachowiak; G Socie; M D Aljurf; M Arat; J J Boelens; R Duarte; A Tichelli; C Peters
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

2.  Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis.

Authors:  Hideaki Ohta; Emiko Miyashita; Ikuko Hirata; Risa Matsumura; Hisao Yoshida; Yoshiko Hashii; Takeshi Higashiura; Takahiro Yasumi; Yuuki Murata; Toshio Heike; Xi Yang; Hirokazu Kanegane; Osamu Ohara; Keiichi Ozono
Journal:  Int J Hematol       Date:  2011-08-24       Impact factor: 2.490

3.  Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma.

Authors:  Reiji Fukano; Tetsuya Mori; Naoto Fujita; Ryoji Kobayashi; Tetsuo Mitsui; Koji Kato; Ritsuro Suzuki; Junji Suzumiya; Takahiro Fukuda; Motohiro Shindo; Nobuo Maseki; Tatsu Shimoyama; Keiko Okada; Masami Inoue; Jiro Inagaki; Yoshiko Hashii; Atsushi Sato; Ken Tabuchi
Journal:  Int J Hematol       Date:  2019-10-16       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.